LRMR Archived Articles
Larimar Therapeutics (NASDAQ:LRMR) - Advancing Novel Therapies for Complex Rare Diseases
Published on March 15, 2025
Larimar Therapeutics (LRMR): Advancing Rare Disease Treatments with Groundbreaking Cell Penetrating Peptide Technology
Published on November 30, 2024
Larimar Therapeutics, Inc. (NASDAQ:LRMR): A Promising Rare Disease Biotech with Significant Upside Potential
Published on September 24, 2024